4AV-15942-51107 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-15
Dose 1 — Pfizer-BioNTech
2021-02-15
Dose 2 — Pfizer-BioNTech
2021-10-30
Registered in v-safe
2021-12-10
Dose 3 — Pfizer-BioNTech
2021-12-11
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain · Fever · Chills, Headache · Be unable to do your normal daily activities

Adult check-in
2021-12-12
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Swelling · Fatigue or tiredness

Adult check-in
2021-12-13
Survey response — days 1–6 daily, dose 3
MedDRA: Unevaluable event — Feeling: Fair · Site: Swelling

Free text: Lymph node

MedDRA releases: 2024-11 · check-in free text available
2021-12-14
Survey response — days 1–6 daily, dose 3
MedDRA: Unevaluable event — Feeling: Fair · Site: Swelling · Headache, Fatigue or tiredness

Free text: Under arm Lymph node was a really

MedDRA releases: 2024-11 · check-in free text available
2021-12-15
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Headache

Adult check-in
2021-12-16
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-15	Pfizer-BioNTech	No
2	2021-02-15	Pfizer-BioNTech	No
3	2021-12-10	Pfizer-BioNTech	No

Free text

Release 10 — days 1–6 daily, dose 3

2021-12-13

Systemic reaction (other): Lymph node

2021-12-14

Systemic reaction (other): Under arm Lymph node was a really

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Unevaluable event	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release